152 related articles for article (PubMed ID: 23577002)
1. FA1 Induces Pro-Inflammatory and Anti-Adipogenic Pathways/Markers in Human Myotubes Established from Lean, Obese, and Type 2 Diabetic Subjects but Not Insulin Resistance.
Abdallah BM; Beck-Nielsen H; Gaster M
Front Endocrinol (Lausanne); 2013; 4():45. PubMed ID: 23577002
[TBL] [Abstract][Full Text] [Related]
2. Primary defects in lipolysis and insulin action in skeletal muscle cells from type 2 diabetic individuals.
Kase ET; Feng YZ; Badin PM; Bakke SS; Laurens C; Coue M; Langin D; Gaster M; Thoresen GH; Rustan AC; Moro C
Biochim Biophys Acta; 2015 Sep; 1851(9):1194-201. PubMed ID: 25819461
[TBL] [Abstract][Full Text] [Related]
3. Reduced insulin-mediated citrate synthase activity in cultured skeletal muscle cells from patients with type 2 diabetes: evidence for an intrinsic oxidative enzyme defect.
Ortenblad N; Mogensen M; Petersen I; Højlund K; Levin K; Sahlin K; Beck-Nielsen H; Gaster M
Biochim Biophys Acta; 2005 Jun; 1741(1-2):206-14. PubMed ID: 15894466
[TBL] [Abstract][Full Text] [Related]
4. Reduced lipid oxidation in myotubes established from obese and type 2 diabetic subjects.
Gaster M
Biochem Biophys Res Commun; 2009 May; 382(4):766-70. PubMed ID: 19324004
[TBL] [Abstract][Full Text] [Related]
5. Artemisia dracunculus L. extract ameliorates insulin sensitivity by attenuating inflammatory signalling in human skeletal muscle culture.
Vandanmagsar B; Haynie KR; Wicks SE; Bermudez EM; Mendoza TM; Ribnicky D; Cefalu WT; Mynatt RL
Diabetes Obes Metab; 2014 Aug; 16(8):728-38. PubMed ID: 24521217
[TBL] [Abstract][Full Text] [Related]
6. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro.
Chacón MR; Miranda M; Jensen CH; Fernández-Real JM; Vilarrasa N; Gutiérrez C; Näf S; Gomez JM; Vendrell J
Int J Obes (Lond); 2008 Jul; 32(7):1122-9. PubMed ID: 18392037
[TBL] [Abstract][Full Text] [Related]
7. Primary defects in lipid handling and resistance to exercise in myotubes from obese donors with and without type 2 diabetes.
Løvsletten NG; Rustan AC; Laurens C; Thoresen GH; Moro C; Nikolić N
Appl Physiol Nutr Metab; 2020 Feb; 45(2):169-179. PubMed ID: 31276628
[TBL] [Abstract][Full Text] [Related]
8. Myotubes from lean and severely obese subjects with and without type 2 diabetes respond differently to an in vitro model of exercise.
Feng YZ; Nikolić N; Bakke SS; Kase ET; Guderud K; Hjelmesæth J; Aas V; Rustan AC; Thoresen GH
Am J Physiol Cell Physiol; 2015 Apr; 308(7):C548-56. PubMed ID: 25608533
[TBL] [Abstract][Full Text] [Related]
9. The diabetic phenotype is preserved in myotubes established from type 2 diabetic subjects: a critical appraisal.
Gaster M
APMIS; 2019 Jan; 127(1):3-26. PubMed ID: 30549138
[TBL] [Abstract][Full Text] [Related]
10. Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjects.
Gaster M; Beck-Nielsen H
Biochim Biophys Acta; 2006 Jan; 1761(1):100-10. PubMed ID: 16442843
[TBL] [Abstract][Full Text] [Related]
11. Electrical pulse stimulation induces differential responses in insulin action in myotubes from severely obese individuals.
Park S; Turner KD; Zheng D; Brault JJ; Zou K; Chaves AB; Nielsen TS; Tanner CJ; Treebak JT; Houmard JA
J Physiol; 2019 Jan; 597(2):449-466. PubMed ID: 30414190
[TBL] [Abstract][Full Text] [Related]
12. Metabolic flexibility is conserved in diabetic myotubes.
Gaster M
J Lipid Res; 2007 Jan; 48(1):207-17. PubMed ID: 17062897
[TBL] [Abstract][Full Text] [Related]
13. Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals.
Kase ET; Thoresen GH; Westerlund S; Højlund K; Rustan AC; Gaster M
Diabetologia; 2007 Oct; 50(10):2171-80. PubMed ID: 17661008
[TBL] [Abstract][Full Text] [Related]
14. Abnormal metabolism flexibility in response to high palmitate concentrations in myotubes derived from obese type 2 diabetic patients.
Kitzmann M; Lantier L; Hébrard S; Mercier J; Foretz M; Aguer C
Biochim Biophys Acta; 2011 Apr; 1812(4):423-30. PubMed ID: 21172433
[TBL] [Abstract][Full Text] [Related]
15. Delta-like 1/fetal antigen-1 (Dlk1/FA1) is a novel regulator of chondrogenic cell differentiation via inhibition of the Akt kinase-dependent pathway.
Chen L; Qanie D; Jafari A; Taipaleenmaki H; Jensen CH; Säämänen AM; Sanz ML; Laborda J; Abdallah BM; Kassem M
J Biol Chem; 2011 Sep; 286(37):32140-9. PubMed ID: 21724852
[TBL] [Abstract][Full Text] [Related]
16. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
[TBL] [Abstract][Full Text] [Related]
17. Expression, biosynthesis and release of preadipocyte factor-1/ delta-like protein/fetal antigen-1 in pancreatic beta-cells: possible physiological implications.
Friedrichsen BN; Carlsson C; Møldrup A; Michelsen B; Jensen CH; Teisner B; Nielsen JH
J Endocrinol; 2003 Feb; 176(2):257-66. PubMed ID: 12553874
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Abdallah BM; Beck-Nielsen H; Gaster M
Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
[TBL] [Abstract][Full Text] [Related]
19. Reduced TCA flux in diabetic myotubes: A governing influence on the diabetic phenotype?
Gaster M
Biochem Biophys Res Commun; 2009 Oct; 387(4):651-5. PubMed ID: 19615969
[TBL] [Abstract][Full Text] [Related]
20. Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.
Thingholm TE; Bak S; Beck-Nielsen H; Jensen ON; Gaster M
Mol Cell Proteomics; 2011 Sep; 10(9):M110.006650. PubMed ID: 21697546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
